BioMonde introduces Larval Debridement Therapy at leading Veterinary conferences

.

BioMonde will be exhibiting its range of Larval Debridement Therapy (LDT) products for the first time at a number of key Veterinary events during Autumn 2018. Despite being available in the UK for over 20 years and utilised by veterinarians for much of this time, BioMonde is pleased to be introducing the benefits of LDT to a wider audience at BEVA, BVNA and the London Vet Show.

With production sites in the UK and Germany, BioMonde is a multinational pharmaceutical company that specialises in the manufacture and distribution of LDT products for chronic wounds. The therapy is backed by a wealth of credible clinical evidence and offers numerous clinical benefits as a form of debridement.

Please visit us at the events below to learn more about the range of products available and to discuss how they could help you overcome some of the challenges that you face in Veterinary wound care:

BEVA
September 12th, 13th, 14th & 15th - ICC Birmingham

BVNA
October 12th, 13th & 14th - Telford International Centre

London Vet Show
November 15th & 16th - ExCel London

BioMonde Logo Small     Cookie PolicyPrivacy & TermsContact

Copyright 2016 BioMonde. All Rights Reserved.
BioMonde, Units 2-4 Dunraven Business Park, Coychurch Road, Bridgend, CF31 3BG, United Kingdom.